Advance your academic career, collaborate globally, and expand your network— join now !

Luis Pardo

Dr. Luis Pardo

Max-Planck-Institut für experimentelle Medizin, AG Oncophysiology, Göttingen, Ge...

Share Link

Share

Information

Luis Pardo's work has focused on the structure and function of ion channels, mainly potassium channels. After the discovery of the implication of KV10 channels in cancer in the late 1990s, the interest of the group is centered on understanding the mechanisms ad roles of potassium channels during tumor progression and on the design of diagnostic and therapeutic tools targeting them. Luis Pardo is a Max-Planck research group leader at the Max Planck Institute of Experimental Medicine, Göttingen, Germany, since 2008. He was affiliated with the Department of Molecular Biology of Neuronal Signals, led by Prof. Walter Stühmer since 1996. Between 2001 and 2004, he served as CSO at iOnGen AG, Göttingen Germany, a company he founded, together with Walter Stühmer and the Max-Planck Society in 2001. From 1993 to 1996, he was a scientist at the Biochemistry Department, University of Oviedo, Spain. Previously, he had received post-doctoral training (1991–1993) in the Department led by Prof. E: Neher at the Max-Planck Institute for Biophysical Chemistry (Göttingen, Germany), after completing his Ph.D. degree at the Biochemistry and Molecular Biology Department at University of Oviedo (Spain). He also received his M.D. from this University in 1986.

Research Keywords & Expertise

Cell Biology
Ion Channels
Neuroscience
Targeted Therapies
Voltage-gated potassiu...

Short Biography

Luis Pardo's work has focused on the structure and function of ion channels, mainly potassium channels. After the discovery of the implication of KV10 channels in cancer in the late 1990s, the interest of the group is centered on understanding the mechanisms ad roles of potassium channels during tumor progression and on the design of diagnostic and therapeutic tools targeting them. Luis Pardo is a Max-Planck research group leader at the Max Planck Institute of Experimental Medicine, Göttingen, Germany, since 2008. He was affiliated with the Department of Molecular Biology of Neuronal Signals, led by Prof. Walter Stühmer since 1996. Between 2001 and 2004, he served as CSO at iOnGen AG, Göttingen Germany, a company he founded, together with Walter Stühmer and the Max-Planck Society in 2001. From 1993 to 1996, he was a scientist at the Biochemistry Department, University of Oviedo, Spain. Previously, he had received post-doctoral training (1991–1993) in the Department led by Prof. E: Neher at the Max-Planck Institute for Biophysical Chemistry (Göttingen, Germany), after completing his Ph.D. degree at the Biochemistry and Molecular Biology Department at University of Oviedo (Spain). He also received his M.D. from this University in 1986.